4868 RUE LEVY, SUITE 220, SAINT-LAURENT, A8
Appoints Hussein Sweiti, M.D., MSc, as Chief Medical Officer
Reports Third Quarter 2025 Financial Results and Provides Business Update
Achieves Target Enrollment Milestone for LEGEND Trial Pivotal Cohort
Appoints Philip Astley-Sparke as Co-Founder and Executive Chairman
Reports Second Quarter 2025 Financial Results and Provides Business Update
Changes in Board, Management or Compensation, Shareholder votes
Material Contracts, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Announces the Resignation of its Chief Medical Officer
Q3
Q2
Q1
Amended Annual Report
FY 2023
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(3)
Registration Statement for Securities Offered under a Shelf Registration
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership